Does targeting Long Noncoding RNA H19 impede maladaptive RV remodeling in right ventricular failure associated with pulmonary arterial hypertension?
Long noncoding RNA H19 is a promising biomarker and therapeutic target for right ventricular failure in pulmonary arterial hypertension.
Our findings identify H19 as a new therapeutic target to impede the development of maladaptive RV remodeling and a promising biomarker of PAH severity and prognosis.
Omura et al. (Thu,) studied this question.